Click on the slide!

Every patient counts

Better organized patient communities attract more research interest - and treatments.

More...
Click on the slide!

Empower patients & researchers

Patients can speed research by sharing their medical history and testing results with researchers. 

More...
Click on the slide!

Share data with researchers

Interested researchers can register to gain access to de-identified patient data and tools.

More...
Click on the slide!

Identify clinical study candidates

Speed treatments to market by identifying pre-validated clinical study candidates.

More...
Frontpage Slideshow (version 2.0.0) - Copyright © 2006-2008 by JoomlaWorks

M.A.P. Project Featured in WSJ

PatientCrossroads collects detailed breast cancer survivor data for the Cancer Support Community M.A.P. Project.

Read the Wall Street Journal article  

 

Download the full report to see how you can harness the power of your community with PatientCrossroads.


 

Lotus Tissue Repair Announces Support of First International Patient Registry for Epidermolysis Bullosa (EB)

Lotus Tissue Repair, Inc., a biotechnology company developing the first and only protein replacement therapy for the treatment of the rare genetic disorder dystrophic epidermolysis bullosa (DEB), today announced that it is providing grants to support the development and maintenance of the first international EB patient-reported registry, EBCare.org.

Learn More

Office of Rare Diseases Research GRDR

The Office of Rare Diseases Research (ORDR) in collaboration with PatientCrossroads, Children Hospital of Philadelphia and WebMD, has launched a pilot program to establish a Global Rare Diseases (Patient) Registry and Data Repository (GRDR) to collect patient clinical information without any personal identifiers (de-identified information), for clinical research.

Learn More

PatientCrossroads
Copyright 2011 Innolyst, Inc.